Common Equity: The sum of all common equity items.
iBio, Inc. (IBIO) had Common Equity of $56.56M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.99M |
|
-- |
|
-- |
|
$9.45M |
|
$-9.45M |
|
$0.45M |
|
$-8.99M |
|
$-8.99M |
|
$-8.99M |
|
$-8.99M |
|
$-8.99M |
|
$-8.99M |
|
$-9.45M |
|
$-9.28M |
|
99.13M |
|
99.13M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$53.37M |
|
$3.45M |
|
$11.03M |
|
$64.39M |
|
$5.90M |
|
-- |
|
$1.93M |
|
$7.83M |
|
|
Common Equity |
$56.56M |
$52.22M |
|
$56.56M |
|
30.05M |
|
| Cash Flow Statement Financials | |
$-10.91M |
|
$-24.48M |
|
$55.49M |
|
$8.79M |
|
$28.90M |
|
$20.11M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.90% |
|
-17.22% |
|
-13.97% |
|
-15.90% |
|
$1.88 |
|
$-0.12 |
|
$-0.11 |
|